NEW
YORK, July 20, 2022 /PRNewswire/ -- The Gross
Law Firm issues the following notice to shareholders of Apyx
Medical Corporation.
Shareholders who purchased shares of APYX during the class
period listed are encouraged to contact the firm regarding possible
lead plaintiff appointment. Appointment as lead plaintiff is not
required to partake in any recovery.
CONTACT US HERE:
https://securitiesclasslaw.com/securities/apyx-medical-corporation-loss-submission-form/?id=29978&from=4
CLASS PERIOD: May 12, 2021
to March 11, 2022
ALLEGATIONS: The complaint alleges that during the class
period, Defendants issued materially false and/or misleading
statements and/or failed to disclose that: (1) a significant number
of Apyx's Advanced Energy products were used for off-label
indications; (2) such off-label uses led to an increase in the
number of medical device reports filed by Apyx reporting serious
adverse events; (3) as a result, the Company was reasonably likely
to incur regulatory scrutiny; (4) as a result of the foregoing, the
Company's financial results would be adversely impacted; and (5) as
a result of the foregoing, defendants' positive statements about
the Company's business, operations, and prospects were materially
misleading and/or lacked a reasonable basis.
DEADLINE: August 5, 2022
Shareholders should not delay in registering for this class action.
Register your information here:
https://securitiesclasslaw.com/securities/apyx-medical-corporation-loss-submission-form/?id=29978&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a
shareholder who purchased shares of APYX during the timeframe
listed above, you will be enrolled in a portfolio monitoring
software to provide you with status updates throughout the
lifecycle of the case. The deadline to seek to be a lead plaintiff
is August 5, 2022. There is no cost
or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally
recognized class action law firm, and our mission is to protect the
rights of all investors who have suffered as a result of deceit,
fraud, and illegal business practices. The Gross Law Firm is
committed to ensuring that companies adhere to responsible business
practices and engage in good corporate citizenship. The firm seeks
recovery on behalf of investors who incurred losses when false
and/or misleading statements or the omission of material
information by a company lead to artificial inflation of the
company's stock. Attorney advertising. Prior results do not
guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-apyx-medical-corporation-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-august-5-2022--nasdaq-apyx-301589551.html
SOURCE The Gross Law Firm